Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 15 - Issue 8 - August 2018

Column

Editor's Corner
Advantages of the Retrograde Approach in Treating Proximal Occlusive Disease
08/28/2018
Craig Walker, MD, comments on a case report of a patient with CLI who was treated with popliteal artery access for a totally occluded right common and external iliac artery as well as a totally occluded right common femoral artery.
Craig Walker, MD, comments on a case report of a patient with CLI who was treated with popliteal artery access for a totally occluded right common and external iliac artery as well as a totally occluded right common femoral artery.
Craig Walker, MD, comments on a...
08/28/2018
Vascular Disease Management
VIdeo
Utilization of Popliteal Artery Access for Occluded Arteries
08/28/2018
In a commentary video, Dr. Craig Walker comments on the use of popliteal artery access for occluded arteries in a patient with critical limb ischemia.
In a commentary video, Dr. Craig Walker comments on the use of popliteal artery access for occluded arteries in a patient with critical limb ischemia.
In a commentary video, Dr. Craig...
08/28/2018
Vascular Disease Management

News

Conference Coverage
Fully Percutaneous Femoropopliteal Bypass: First-of-its-Kind Procedure for Patients With Peripheral Artery Disease
08/28/2018
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how percutaneous femoropopliteal bypass, a relatively new intervention, may be a potential solution for meeting unmet needs in patients with peripheral artery disease.
Jihad Mustapha, MD, explains how...
08/28/2018
Vascular Disease Management

Feature

Case Report
Novel Balloon Angioplasty Technique for Common Femoral Artery Dissection
08/28/2018
This case demonstrates the steps of sealing a flow limiting, iatrogenic CFA dissection during primary percutaneous coronary intervention, including a novel balloon angioplasty technique.
This case demonstrates the steps of sealing a flow limiting, iatrogenic CFA dissection during primary percutaneous coronary intervention, including a novel balloon angioplasty technique.
This case demonstrates the steps...
08/28/2018
Vascular Disease Management
Case Report
Retrograde Popliteal Artery Access for Angioplasty of Chronic Total Occlusion of the Iliofemoral Artery
08/28/2018
Ramachandra Barik, MD, DNB, reports on a case of a patient with peripheral angioplasty and chronic total occlusion of the right femoropopliteal with total occlusion of contralateral side of the common femoral artery.
Ramachandra Barik, MD, DNB, reports on a case of a patient with peripheral angioplasty and chronic total occlusion of the right femoropopliteal with total occlusion of contralateral side of the common femoral artery.
Ramachandra Barik, MD, DNB,...
08/28/2018
Vascular Disease Management

Meeting Materials

Scientific Abstracts
Selected AMPutation Prevention Symposium 2018 Abstracts
08/28/2018
A round-up of scientific abstracts presented at the AMP Symposium on August 8-11, 2018, in Chicago, Illinois.
A round-up of scientific abstracts presented at the AMP Symposium on August 8-11, 2018, in Chicago, Illinois.
A round-up of scientific...
08/28/2018
Vascular Disease Management

Insights

Interview
Geniculate Artery Embolization Offers Pain Relief From Osteoarthritis
08/28/2018
Rachel Piechowiak, DO, discusses the implications of a US clinical trial which investigated the use of geniculate artery embolization for decreasing inflammation and pain in osteoarthritis.
Rachel Piechowiak, DO, discusses the implications of a US clinical trial which investigated the use of geniculate artery embolization for decreasing inflammation and pain in osteoarthritis.
Rachel Piechowiak, DO, discusses...
08/28/2018
Vascular Disease Management
Interview
Registry Data Explores Current Practice of Endovascular Therapy in Korea
08/28/2018
In this Q&A, Donghoon Choi, MD, PhD, comments on data from the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry.
In this Q&A, Donghoon Choi, MD, PhD, comments on data from the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry.
In this Q&A, Donghoon Choi, MD,...
08/28/2018
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

August 2018 Volume 15 Issue 8

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement